Use of Model-Based Iterative Reconstruction (MBIR) in reduced-dose CT for routine follow-up of patients with malignant lymphoma: dose savings, image quality and phantom study

European Radiology
Edouard HérinAlain Luciani

Abstract

To evaluate both in vivo and in phantom studies, dose reduction, and image quality of body CT reconstructed with model-based iterative reconstruction (MBIR), performed during patient follow-ups for lymphoma. This study included 40 patients (mean age 49 years) with lymphoma. All underwent reduced-dose CT during follow-up, reconstructed using MBIR or 50 % advanced statistical iterative reconstruction (ASIR). All had previously undergone a standard dose CT with filtered back projection (FBP) reconstruction. The volume CT dose index (CTDIvol), the density measures in liver, spleen, fat, air, and muscle, and the image quality (noise and signal to noise ratio, SNR) (ANOVA) observed using standard or reduced-dose CT were compared both in patients and a phantom study (Catphan 600) (Kruskal Wallis). The CTDIvol was decreased on reduced-dose body CT (4.06 mGy vs. 15.64 mGy p < 0.0001). SNR was higher in reduced-dose CT reconstructed with MBIR than in 50 % ASIR or than standard dose CT with FBP (patients, p ≤ 0.01; phantoms, p = 0.003). Low contrast detectability and spatial resolution in phantoms were not altered on MBIR-reconstructed CT (p ≥ 0.11). Reduced-dose CT with MBIR reconstruction can decrease radiation dose delivered to patient...Continue Reading

References

Mar 29, 2006·European Radiology·E CoppenrathU G Mueller-Lisse
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Nov 30, 2007·The New England Journal of Medicine·David J Brenner, Eric J Hall
Dec 13, 2007·Medical Physics·Jean-Baptiste ThibaultJiang Hsieh
Apr 29, 2008·The British Journal of Radiology·E J Hall, D J Brenner
Oct 14, 2008·Health Physics·Fred A MettlerMahadevappa Mahesh
Aug 22, 2009·AJR. American Journal of Roentgenology·Amy K HaraWilliam Pavlicek
Dec 24, 2009·AJR. American Journal of Roentgenology·Alvin C SilvaWilliam Pavlicek
Aug 24, 2010·AJR. American Journal of Roentgenology·Jonathon LeipsicJames P Earls
Jan 21, 2011·European Radiology·Dominik Fleischmann, F Edward Boas
Dec 23, 2011·The British Journal of Radiology·M-O BernierD Laurier
Feb 10, 2012·Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)·Marcel BeisterWilli A Kalender
Aug 24, 2012·Radiology·David J Brenner, Eric J Hall
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H TillyUNKNOWN ESMO Guidelines Working Group
Nov 20, 2012·Lancet·François GardavaudAlain Rahmouni
Feb 22, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M DreylingE Zucca
Jan 17, 2014·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Ravi K KazaAmit Pandya
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonT Andrew Lister
Sep 6, 2014·Journal of the National Comprehensive Cancer Network : JNCCN·Andrew D ZelenetzUNKNOWN National comprehensive cancer network

❮ Previous
Next ❯

Citations

Apr 16, 2018·Journal of Medical Imaging and Radiation Oncology·Fiachra MoloneyOwen J O'Connor
Sep 21, 2019·Journal of Applied Clinical Medical Physics·Claudia MillerCarri Glide-Hurst

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.